Methods of treating fabry disease in patients having renal impairment
AssigneeAmicus Therapeutics, Inc.
InventorFranklin Johnson
Life of this patent
Estimating the term…
Abstract
Provided are methods of treating Fabry disease in a patient having severe renal impairment. A method for the treatment of Fabry disease in a patient having severe renal impairment, including administering to the patient about 50 mg to about 200 mg free base equivalent (FBE) of migalastat or salt thereof at a frequency of less than once every week. A method for the treatment of Fabry disease in a patient having severe renal impairment, including administering to the patient about 50 mg to about 100 mg free base equivalent of migalastat or salt thereof at a frequency of between about once every three days and about once every two weeks.
Claims32
A method for the treatment of Fabry disease in a patient having severe renal impairment, the method comprising administering to the patient about 50 mg to about 200 mg free base equivalent (FBE) of migalastat or salt thereof at a frequency of less than once every week.
A method for the treatment of Fabry disease in a patient having severe renal impairment, the method comprising administering to the patient about 50 mg to about 100 mg free base equivalent (FBE) of migalastat or salt thereof at a frequency of between about once every three days and about once every two weeks.
Use of migalastat in the treatment of Fabry disease in a patient having severe renal impairment, the use of migalastat comprising administering to the patient about 50 mg to about 300 mg free base equivalent (FBE) of migalastat or salt thereof at a frequency of less than once every week.
Use of migalastat in the treatment of Fabry disease in a patient having severe renal impairment, the use of migalastat comprising administering to the patient about 50 mg to about 100 mg free base equivalent (FBE) of migalastat or salt thereof at a frequency of between about once every three days and about once every two weeks.
Dependencies are inferred from the claim text.